This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pien, B. C.
Right arrow Articles by Woods, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pien, B. C.
Right arrow Articles by Woods, C. W.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2007, p. 1357-1359, Vol. 45, No. 4
0095-1137/07/$08.00+0     doi:10.1128/JCM.02091-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Controlled Clinical Comparison of BacT/ALERT Standard Aerobic and Standard Anaerobic Blood Culture Bottles Inoculated Directly or after Transport in Sodium Polyanethol Sulfonate Tubes{triangledown}

Brian C. Pien,1,2 Stanley Mirrett,1 Betty R. Crews,2 L. Barth Reller,1,3,4 and Christopher W. Woods2,3,4*

Clinical Microbiology Laboratory, Duke University Medical Center,1 Durham Veterans Affairs Medical Center,2 Departments of Pathology,3 Medicine, Duke University School of Medicine, Durham, North Carolina4

Received 11 October 2006/ Returned for modification 29 November 2006/ Accepted 22 January 2007


arrow
ABSTRACT
 
To assess relative performances in the BacT/ALERT blood culture system, we compared results from the direct inoculation of standard media and inoculation after the transport of blood samples in Vacutainer tubes with sodium polyanethol sulfonate. No significant differences in yields or times to detection were found for 387 clinically important isolates from 4,306 blood culture sets.


arrow
TEXT
 
Sodium polyanethol sulfonate (SPS) is a common component of blood culture media, owing to its anticoagulant, anticomplement, and antiphagocytic properties (2, 3, 17, 18). It also inactivates lysozyme, aminoglycosides, and polymyxins (1). Although SPS has been shown to improve the recovery of commonly isolated microorganisms in older medium formulations (3, 5, 8, 12, 13, 16), it inhibits the growth of Peptostreptococcus anaerobius, Neisseria gonorrhoeae, Neisseria meningitidis, Streptobacillus moniliformis, Gardnerella vaginalis, Haemophilus ducreyi, and Capnocytophaga spp. (4, 7, 11, 14).

For four decades, Vacutainer SPS tubes (BD Diagnostic Systems, Franklin Lakes, NJ) have been used at the Durham Veterans Affairs Medical Center, Durham, NC, and other institutions to transport whole blood until it can be inoculated into culture media. The historical advantages of this approach include being able to inoculate a variety of culture media and having plasma for serological testing (15). The effect that SPS transport tubes have on the yields from currently used blood culture media, however, has not been reported. Furthermore, the transfer of tube contents poses a percutaneous injury risk to laboratory staff. Consequently, we performed a controlled comparison of direct inoculation into standard BacT/ALERT (BA; bioMérieux, Inc., Durham, NC) blood culture bottles and inoculation after transport in SPS tubes.

(This work was presented in part at the 104th General Meeting of the American Society for Microbiology in 2004 [B.C. Pien, S. Mirrett, B. Crews, L. B. Reller, and C. W. Woods, abstr. C080].)

Blood cultures were collected from adult patients at the Durham Veterans Affairs Medical Center between January 2003 and March 2005. Institutional Review Board approval was obtained, and all blood cultures were performed as part of routine care. Four-bottle kits were provided with instructions to obtain 30 ml of blood per set and to distribute 7.5 ml sequentially into a standard aerobic (SA) bottle, an SPS tube, a standard anaerobic (SN) bottle, and a second SPS tube without changing needles. Uninoculated SPS tubes contained 1.7 ml of 0.35% SPS in 0.85% sodium chloride. The SA and SN bottles each contained 40 ml of supplemented tryptic soy broth with 0.035% SPS.

The filling adequacy (adequate, underfilled, or overfilled) of each bottle was measured against marked volumetric standards; 6 to 9 ml of blood was considered adequate. All bottles were processed regardless of the volume received. The contents of each SPS tube were transferred into additional SA and SN bottles in a biological safety cabinet. All four bottles were loaded onto the BA instrument and incubated for 5 days or until they were flagged as positive. The contents from flagged bottles were subcultured, and isolates were identified according to standard techniques (10).

An infectious disease physician reviewed the record of each patient with a positive blood culture to determine whether an isolate represented true infection, contamination, or unknown clinical importance. These assessments were made in accordance with published criteria (19). An episode of bacteremia or fungemia was defined as a period beginning with the first positive blood culture and ending when 7 days had passed without another blood culture positive for the same microorganism.

We compared rates of recovery from sets of adequately filled bottles with the chi-square test of McNemar by using Stata 9 (StataCorp, College Station, TX) and reported results as a two-sided P value. A prespecified {alpha} significance level of 0.05 was used. Mean times to detection were compared using the Wilcoxon rank sum test for nonparametric data. Assuming 100% specificity for either blood culture method when a clinically significant isolate was obtained, test sensitivities with 95% confidence intervals (95% CI) were calculated for each blood culture method.

Of the original 8,788 sets of blood cultures, 937 (11%) were positive with one or more isolates. Among the 4,306 (49%) adequately filled four-bottle sets, there were 387 (9.0%) with clinically significant isolates, representing 293 episodes, and 164 (3.8%) with one or more contaminants. No needle stick injuries occurred in the microbiology laboratory during the study period.

We did not find any significant differences between the methods in rates of recovery of staphylococci, Enterobacteriaceae, nonenteric gram-negative bacilli, anaerobes, Candida spp. and Cryptococcus spp., and all clinically significant microorganisms combined (Table 1). Both methods also had similar levels of detection of clinically important episodes, with mean overall sensitivities of 91% (95% CI, 88 to 94%) and 92% (95% CI, 88 to 95%) for direct inoculation and the SPS tube method, respectively (Table 2). The mean times to detection and the comparative yields of clinically significant isolates obtained while patients received effective antimicrobial therapy also did not differ significantly (data not shown); however, the SPS tubes yielded fewer contaminating microorganisms (P = 0.03; Table 3).


View this table:
[in this window]
[in a new window]

 
TABLE 1. Comparative yields of clinically important isolates after SPS transport and after direct inoculation into BacT/ALERT SA and SN bottles


View this table:
[in this window]
[in a new window]

 
TABLE 2. Comparative yields of clinically important episodes detected after SPS transport and after direct inoculation into BacT/ALERT SA and SN bottles


View this table:
[in this window]
[in a new window]

 
TABLE 3. Comparative yields of contaminant isolates after SPS transport and after direct inoculation into BacT/ALERT SA and SN bottles

The SPS transport tube was designed to allow microbiologists to inoculate different media in the laboratory without stocking the more expensive blood culture bottles in hospital units or clinics. Although the laboratory time required to transfer tube contents into blood culture media and the finite needle stick injury risk may increase net expenses, about 7 million SPS tubes are purchased annually (B. McLaughlin, personal communication). Furthermore, the SPS tube may be useful for direct PCR detection of bloodstream pathogens. Although SPS tends to copurify with DNA and inhibit PCR, a benzyl alcohol organic extraction procedure has been described previously (6).

BA bottles inoculated with blood from the SPS transport system have a final SPS concentration slightly higher than those inoculated directly (0.041% compared to 0.030%). However, blood may remain for several hours in the transport tubes containing a concentration of SPS (0.065%) twice that of directly inoculated BA bottles. This difference could affect the recovery of clinically important isolates and contaminants in laboratories that are located offsite or that are not operated 24 h daily.

It was unexpected to find that the SPS transport tubes had fewer contaminants, since the use of the tubes requires an additional specimen transfer step which may increase the risk of contamination. The reason for this observation, however, is not clear in that SPS tubes do not appear to inhibit the detection of clinically significant staphylococci. Two previous studies showed that the addition of SPS was associated with increased contamination; however, transport tubes were not used and the comparison media did not contain SPS (3, 9).

In conclusion, no significant differences in the rates of recovery of clinically important isolates after transport in SPS tubes and after direct inoculation into standard BA bottles were detected. Although fewer contaminating microorganisms may be recovered, transport in SPS tubes requires additional processing in the laboratory, including the transfer of blood.


arrow
ACKNOWLEDGMENTS
 
This work was supported by a Department of Veterans Affairs Special Fellowship Program in Health Services Research (B.C.P.) and grant UO1AI066569 from the National Institute of Allergy and Infectious Diseases (C.W.W.).

Media were provided in part by bioMérieux, Inc., Durham, NC.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Durham VA Medical Center, Section 113, 508 Fulton St., Durham, NC 27705. Phone: (919) 286-0411, ext. 6681. Fax: (919) 684-8519. E-mail: woods004{at}mc.duke.edu Back

{triangledown} Published ahead of print on 31 January 2007. Back


arrow
REFERENCES
 
    1
  1. Edberg, S. C., C. J. Bottenbley, and K. Gam. 1976. Use of sodium polyanethol sulfonate to selectively inhibit aminoglycoside and polymyxin antibiotics in a rapid blood level antibiotic assay. Antimicrob. Agents Chemother. 9:414-417.[Abstract/Free Full Text]
  2. 2
  3. Ellner, P. D., and C. J. Stoessel. 1966. The role of temperature and anticoagulant on the in vitro survival of bacterial in blood. J. Infect. Dis. 116:238-242.[Medline]
  4. 3
  5. Eng, J. 1975. Effect of sodium polyanethol sulfonate in blood cultures. J. Clin. Microbiol. 1:119-123.[Abstract/Free Full Text]
  6. 4
  7. Eng, J., and H. Iveland. 1975. Inhibitory effect in vitro of sodium polyanethol sulfonate on the growth of Neisseria meningitidis. J. Clin. Microbiol. 1:444-447.[Abstract/Free Full Text]
  8. 5
  9. Finegold, S. M., I. Ziment, M. L. White, W. R. Winn, and W. T. Carter. 1967. Evaluation of polyanethol sulfonate (liquoid) in blood cultures. Antimicrob. Agents Chemother. 7:692-696.[Medline]
  10. 6
  11. Fredricks, D. N., and D. A. Relman. 1998. Improved amplification of microbial DNA from blood cultures by removal of the PCR inhibitor sodium polyanetholsulfonate. J. Clin. Microbiol. 36:2810-2816.[Abstract/Free Full Text]
  12. 7
  13. Graves, M. H., J. A. Morello, and F. E. Kocka. 1974. Sodium polyanethol sulfonate sensitivity of anaerobic cocci. Appl. Microbiol. 27:1131-1133.[Medline]
  14. 8
  15. Hall, M., E. Warren, and J. A. Washington. 1974. Detection of bacteremia with liquid media containing sodium polyanetholsulfonate. Appl. Microbiol. 27:187-191.[Medline]
  16. 9
  17. Minkus, R., and H. L. Moffet. 1971. Detection of bacteremia in children with sodium polyanethol sulfonate: a prospective clinical study. Appl. Microbiol. 22:805-808.[Medline]
  18. 10
  19. Murray, P. R., E. J. Baron, M. A. Pfaller, J. H. Jorgensen, and R. H. Yolken. 2003. Manual of clinical microbiology. ASM Press, Washington, DC.
  20. 11
  21. Reimer, L. G., and L. B. Reller. 1985. Effect of sodium polyanetholesulfonate and gelatin on the recovery of Gardnerella vaginalis from blood culture media. J. Clin. Microbiol. 21:686-688.[Abstract/Free Full Text]
  22. 12
  23. Rosner, R. 1968. Effect of various anticoagulants and no anticoagulant on ability to isolate bacteria directly from parallel clinical blood specimens. Am. J. Clin. Pathol. 49:216-219.[Medline]
  24. 13
  25. Shanson, D. C., F. D. Thomas, and D. Johnstone. 1985. Improving detection of "Viridans streptococcus" bacteraemia by adding sodium polyanethol sulphonate to blood cultures. J. Clin. Pathol. 38:1346-1348.[Abstract/Free Full Text]
  26. 14
  27. Shawar, R., J. Sepulveda, and J. E. Clarridge. 1990. Use of the RapID-ANA system and sodium polyanetholesulfonate disk susceptibility testing in identifying Haemophilus ducreyi. J. Clin. Microbiol. 28:108-111.[Abstract/Free Full Text]
  28. 15
  29. Stuart, R. D. 1948. The value of Liquoid for blood culture. J. Clin. Pathol. 1:311-314.[Free Full Text]
  30. 16
  31. Tenney, J. H., L. B. Reller, W. L. Wang, R. L. Cox, and S. Mirrett. 1982. Comparative evaluation of supplemented peptone broth with sodium polyanetholesulfonate and Trypticase soy broth with sodium amylosulfate for detection of septicemia. J. Clin. Microbiol. 16:107-110.[Abstract/Free Full Text]
  32. 17
  33. Traub, W. H., and B. L. Lowrance. 1970. Anticomplementary, anticoagulatory, and serum-protein precipitating activity of sodium polyanetholsulfonate. Appl. Microbiol. 20:465-468.[Medline]
  34. 18
  35. von Haebler, T., and A. A. Miles. 1938. The action of sodium polyanethol sulphonate "Liquoid" on blood cultures. J. Pathol. Bacteriol. 46:245-252.
  36. 19
  37. Weinstein, M. P., M. L. Towns, S. M. Quartey, S. Mirrett, L. G. Reimer, G. Parmigiani, and L. B. Reller. 1997. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis. 24:584-602.[Medline]


Journal of Clinical Microbiology, April 2007, p. 1357-1359, Vol. 45, No. 4
0095-1137/07/$08.00+0     doi:10.1128/JCM.02091-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pien, B. C.
Right arrow Articles by Woods, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pien, B. C.
Right arrow Articles by Woods, C. W.